Libbs Farmacêutica

Libbs Farmacêutica is one of the largest and most respected 100% Brazilian-owned pharmaceutical companies. Founded in 1958, the company is a leader in the domestic market, specializing in a wide range of therapeutic areas including cardiology, oncology, gynecology, and the central nervous system. Libbs is recognized for its significant investment in research and development, particularly in the field of biotechnology and biosimilars. The company operates a state-of-the-art industrial complex in Embu das Artes, São Paulo, which includes 'Biotec,' the first industrial-scale monoclonal antibody plant in Brazil. Libbs is committed to expanding access to high-quality healthcare through innovative treatments and has recently ventured into the production of high-potency oral chemotherapies and vaccine raw materials. They aim to triple their revenue by 2032 through aggressive expansion in the biologics and specialized medicine sectors.